Citigroup’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
6116
2024
Q4
Hold
0
6064
2024
Q3
Hold
0
5889
2024
Q2
Hold
0
5554
2024
Q1
Hold
0
5600
2023
Q4
Hold
0
5659
2022
Q3
Hold
0
6540
2022
Q2
Sell
-4
Closed -$1.91K 6830
2022
Q1
$3K Buy
+4
New +$2.21K ﹤0.01% 6014
2021
Q3
Hold
0
6443
2021
Q2
Hold
0
6504
2021
Q1
Hold
0
7682
2020
Q4
Hold
0
7699
2020
Q3
Hold
0
7652
2020
Q2
Hold
0
7735
2020
Q1
Hold
0
7832
2019
Q4
Hold
0
7855
2019
Q3
Hold
0
7865
2019
Q2
Hold
0
7889
2019
Q1
Hold
0
7871
2018
Q4
Hold
0
7884
2018
Q3
Hold
0
7911
2018
Q2
Hold
0
7790
2018
Q1
Hold
0
7720
2017
Q4
Hold
0
7690
2017
Q3
Hold
0
7512
2017
Q2
Hold
0
7536
2017
Q1
Hold
0
7388
2016
Q4
Hold
0
7371
2016
Q3
Hold
0
7243
2016
Q2
Hold
0
7541
2016
Q1
Hold
0
7862
2015
Q4
Hold
0
7952
2015
Q3
Hold
0
7829
2015
Q2
Hold
0
7832
2015
Q1
Hold
0
7505
2014
Q4
Hold
0
7383

Other funds holding APTO

Citigroup's APTO Position: Q1 2025 in Review

Citigroup held its Aptose Biosciences, Inc. (APTO) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6116.

Citigroup first reported a position in APTO in Q1 2022 and has held it in 1 quarter since. The position peaked at $3K in Q1 2022. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.

  • Citigroup held 0 shares of Aptose Biosciences, Inc. worth $0 as of Q1 2025.
  • Citigroup left its Aptose Biosciences, Inc. share count unchanged in Q1 2025.
  • Aptose Biosciences, Inc. made up ﹤0.01% of Citigroup's portfolio in Q1 2025, its #6116 holding.
  • Citigroup first reported a position in Aptose Biosciences, Inc. in Q1 2022 and has held it in 1 quarter since.
  • Citigroup's Aptose Biosciences, Inc. position peaked at $3K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.